Login / Signup

Platelet rich clots are resistant to lysis by thrombolytic therapy in a rat model of embolic stroke.

Amelia J TomkinsNadine SchleicherLucy MurthaManfred KapsChristopher R LeviMax NedelmannNeil J Spratt
Published in: Experimental & translational stroke medicine (2015)
Site specific delivery of platelet rich clots to the MCA origin resulted in high rates of MCA occlusion, low rates of spontaneous clot lysis and large infarction. These platelet rich clots were highly resistant to tPA with or without microbubble-enhanced sonothrombolysis. This resistance of platelet rich clots to enhanced thrombolysis may explain recanalization failures clinically and should be an impetus to better clot-type identification and alternative recanalization methods.
Keyphrases
  • pulmonary embolism
  • acute ischemic stroke
  • middle cerebral artery
  • atrial fibrillation
  • endovascular treatment
  • stem cells
  • bone marrow
  • cell therapy